Caxton Associates (New York)’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-66,934
Closed -$2.72M 621
2024
Q3
$2.72M Buy
66,934
+18,695
+39% +$707K 0.1% 79
2024
Q2
$1.65M Buy
+48,239
New +$1.52M 0.06% 178
2022
Q2
Sell
-12,641
Closed -$394K 692
2022
Q1
$394K Sell
12,641
-8,333
-40% -$246K 0.03% 308
2021
Q4
$621K Buy
+20,974
New +$612K 0.06% 222
2021
Q3
Sell
-9,516
Closed -$345K 552
2021
Q2
$345K Sell
9,516
-6,036
-39% -$224K 0.04% 269
2021
Q1
$570K Buy
+15,552
New +$572K 0.05% 141

Other funds holding OHI

Caxton Associates (New York)'s OHI Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Omega Healthcare (OHI) in Q4 2024, closing a stake of 66,934 shares — an estimated $2.72M sold.

Caxton Associates (New York) first reported a position in OHI in Q1 2021 and held it in 6 quarters. The position peaked at $2.72M in Q3 2024. 622 funds tracked by Wall St. Rank hold OHI as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Omega Healthcare position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 66,934 Omega Healthcare shares in Q4 2024, an estimated $2.72M.
  • Caxton Associates (New York) first reported a position in Omega Healthcare in Q1 2021 and held it in 6 quarters.
  • Caxton Associates (New York)'s Omega Healthcare position peaked at $2.72M in Q3 2024.
  • 622 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.